Profile
Jaivir Pall is the founder of Well Technologies Ltd, which was founded in 2018.
He is currently working as an Investment Director at Zubi Capital since 2023 and as an Advisor at BioSapien, Inc. since 2020.
Mr. Pall completed his undergraduate degree from the University of Warwick in 2012.
Jaivir Pall active positions
| Companies | Position | Start |
|---|---|---|
Harbr /UK/
 Harbr /UK/ Investment ManagersFinance Well Technologies Ltd (Harbr) is a venture capital firm founded in 2017 by Daniel Omar and Jaivir Pall. The firm is headquartered in Birmingham, United Kingdom. | Founder | 2018-03-31 |
BioSapien, Inc.
 BioSapien, Inc. Packaged SoftwareTechnology Services BioSapien, Inc. is a company that offers a joint solution to the problems of surgery and chemotherapy. The company is based in New York, NY. The company's technology, medichip™, is a delivery platform designed to deliver drugs directly onto a local site, with an initial indication for treating locally advanced unresectable tumor(s). The company aims to reduce patient burden and decrease patient non-compliance caused by the serious side effect profile of systemic chemotherapy. The company was founded by Khatija Ali, who has been the CEO since incorporation. | Consultant / Advisor | 2020-01-31 |
| Zubi Capital | Private Equity Investor | 2023-01-31 |
Training of Jaivir Pall
| University of Warwick | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Harbr /UK/
Harbr /UK/ Investment ManagersFinance Well Technologies Ltd (Harbr) is a venture capital firm founded in 2017 by Daniel Omar and Jaivir Pall. The firm is headquartered in Birmingham, United Kingdom. | Finance |
BioSapien, Inc.
BioSapien, Inc. Packaged SoftwareTechnology Services BioSapien, Inc. is a company that offers a joint solution to the problems of surgery and chemotherapy. The company is based in New York, NY. The company's technology, medichip™, is a delivery platform designed to deliver drugs directly onto a local site, with an initial indication for treating locally advanced unresectable tumor(s). The company aims to reduce patient burden and decrease patient non-compliance caused by the serious side effect profile of systemic chemotherapy. The company was founded by Khatija Ali, who has been the CEO since incorporation. | Technology Services |
| Zubi Capital | Finance |
- Stock Market
- Insiders
- Jaivir Pall
